Islamabad: The Competition Appellate Tribunal (CAT) has upheld a decision by the Competition Commission of Pakistan (CCP) against Neucon Pakistan for the fraudulent use of trademarks, related to the marketing of a product similar to Biofreeze Gel and Spray, developed by the U.S.-based Performance Health Inc.
According to Competition Commission of Pakistan, the CCP had initially issued a Show Cause Notice to Neucon Pakistan following a complaint from Ferozsons Laboratories Limited, the authorized distributor of Biofreeze in Pakistan. The complaint accused Neucon of marketing a product called ‘BYQFREEZ,’ which closely imitated the trademark, packaging, and labeling of Biofreeze.
The CCP’s investigation confirmed that Performance Health Inc. holds the Biofreeze trademark and that Ferozsons is the sole registered distributor in Pakistan. Neucon was found to have no authorization to use or replicate the Biofreeze branding, leading to a CCP-imposed fine of PKR 2.5 million for violating the Competition Act, 2010. Neucon’s appeal to the CAT was dismissed on May 21, 2024, affirming the CCP’s ruling.